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Condensation of bifunctional 1-aminoisoindole with bis-electrophilic methyl 4-chloro-3-
oxobutanoate undergoes regioselectively to afford 2-(chloromethyl)-2-hydroxy-2,6-dihydro-
pyrimido[2,1-a]isoindol-4(3H)-one. The structure of the reaction product was unambiguously 
established by HMQC and HMBC heteronuclear correlations. The functionalization of the 
synthesized compound by reactions with a series of aliphatic amines was carried out. 
_______________________________________________________________________________ 
Introduction 
Isoindole derivatives are widely used for the 
development of new drugs [1–7], as dyes, pigments 
and fluorophores in materials science [1, 8–11], as 
well as markers in analytical chemistry [1].  
The 1-aminoisoindole is often used as 
unsymmetrical 1,3-NCN-binucleophilic building 
block in the synthesis of various isoindole-based 
fused heterocyclic systems. Thus, its reaction with 
ethyl 5-acetyl-3,4-dihydropyridine-1(2H)-
carboxylate leads to regioselective formation of 
pyrimido[2,1-a]isoindole derivative [12], while 
condensation of 1-aminoisoindole with phthaloyl 
chloride [13] or o-chloromethylbenzonitrile and 
further treatment with sodium ethanolate [14] results 
in isoindolo[2,1-b][2,4]benzodiazepine derivatives. 
Reactions of 1-aminoisoindole with various 
αhaloketones, diketones and keto esters 
leading to the formation of 5H-imidazo[2,1-
a]isoindole and 6H-pyrimido[2,1-a]isoindole 
derivatives, respectively, have also been studied [15–
17]. To the best of our knowledge, condensation of 1-
aminoisoindole derivatives with 4-halogen-3-
oxobutanoates were not described to date, although 
the latter are very common reagents in 
heterocyclization with various amidine-containing 
substrates. The molecule of 4-halogen-3-
oxobutanoate contains several reaction centers and 
could play a role of 1,3-CCC- as well as 1,2-CC-
biselectrophile; that ensures the variability of the 
reactions and the synthetical diversity of the products 
obtained. For example, its condensation with 
different amidines leads to the formation of 
substituted pyrrolo[2,3-d]pyrimidines [18], 
imidazo[1,2-a]pyridines [19], thiazolo[3,2-
b][1,2,4]triazoles [20], benzo[d]imidazo[2,1-
b]thiazoles [21], imidazo[1,2-a]pyrazines [22], 
pyrido[1,2-a]pyrimidines [23] etc. 
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Results and discussion 
Herein, we report our studies on the 
condensation of 1-aminoisoindole hydrobromide with 
methyl 4-chloro-3-oxobutanoate. The reaction was 
carried out in dry dioxane in the presence of 
triethylamine. As a result of heterocyclization, a 
product was obtained in moderate yield (46%). This 
product may have one of two alternative regioisomeric 
structures 3a or 3b (Scheme 1). It should be noted that 
we have not found any literature examples on reaction 
of amidines with 4-halogeno-3-oxobutanoates, where 
both chloromethyl fragment and OH group were 
simultaneously present in the product structure at the 
same carbon atom. Such type of reactions commonly 
occurred under rather severe conditions, often upon 
heating in polyphosphoric acid [24], and were 
accompanied by water molecule elimination. 
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Scheme 1. Reaction of 1-aminoisoindole 1 with methyl-4-chloro-3-oxobutanoate  2. 
Structures 3a and 3b have similar spin 
systems; therefore, they cannot be distinguished on the 
basis of 1H and 13C NMR spectra. To solve this 
problem, we recorded HMQC and HMBC 
heteronuclear 13C–1H correlation spectra of the 
compound 3 (through one and 2–3 chemical bonds, 
respectively). The coordinates of the cross-peaks 
found in the HMQC and HMBC spectra are shown in 
Table 1.  
Correlations through one chemical bond in the 
HMQC spectrum allowed assigning signals from 
carbon atoms linked to hydrogen, and quaternary 
carbon atoms were identified by analysis of 
correlations through 2–3 chemical bonds in the 
HMBC spectrum. Here, the most important 
correlation was the one between the methylene group 
protons of the isoindoline fragment (δ 4.79 ppm) and 
the carbon atom C=O group (δ 166.0 ppm). Such 
correlation indicates that there are no more than three 
chemical bonds between these atoms. 
Table 1. Heteronuclear 1H–13C correlations found for 
compound 3. 
 ppm HMQC HMBC 
7.82 124.0 155.9; 141.2; 133.1; 124.5 
7.63 133.1; 124.5 141.2; 135.5; 129.0; 124.0; 
48.6 
7.47 129.0 141.2; 124.0; 124.5 
6.15 - - 
4.79 48.6 166.0; 155.9; 141.2; 135.5; 
129.0; 124.5 
3.63 52.0 86.2; 39.0 
3.68 52.0 86.2; 39.0 
2.80 39.0 166.0; 86.2; 52.0 
2.62 39.0 166.0; 86.2; 52.0 
This allows to assign structure of the reaction 
product as 2-(chloromethyl)-2-hydroxy-2,6-dihydro-
pyrimido[2,1-a]isoindol-4(3H)-one (3a). In the 
alternative molecule 3b, the carbonyl carbon atom and 
the methylene group protons are separated by 5 
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chemical bonds, which does not allow for the spin-spin 
coupling between them. 
N
N
O
HO Cl
H
H
H
H
H
H
HH
H
H
124.0
135.5
155.9
141.2
48.6
4.79
86.2
39.0
166.0
52.0
2.80
2.62
3.633.68
7.63
124.5
7.63
133.1
129.0
7.47
7.82
6.15
 
Figure 1. Signals assignment of 1H and 13C NMR spectra 
for 3a according to HMQC and HMBC. 
Figure 1 shows the chemical shifts of protons 
and carbon nuclei in the molecule 3a, as well as the 
principal correlations in the HMBC spectrum. 
To further study chemical properties of 
pyrimido[2,1-a]isoindolone 3a, we introduced this 
compound into reactions with a series of aliphatic 
amines (Scheme 2). The reaction was carried out in dry 
toluene with large excess of amine, which acted both 
as a reagent and a base. Derivatives 4 were isolated in 
good yields using column chromatography. 
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Scheme 2. Reaction of 3a with aliphatic amines. 
Experimental part 
NMR spectra were obtained on Mercury 400 
Varian spectrometer at 400 MHz (1H NMR) or 100 
MHz (13C NMR) in DMSO-d6. All chemical shifts 
were referenced to the TMS residual peak as an 
internal standard. The heteronuclear HMQC and 
HMBC correlation spectra were recorded using a 
method of indirect detection of carbon signals and 
gradient selection of useful signals. Melting points 
were determined with a Boetius microscope hot plate 
apparatus. Mass spectra were recorded on an Agilent 
1100 LC/MSD SL instrument with chemical 
ionization. 
2-(Chloromethyl)-2-hydroxy-2,6-
dihydropyrimido[2,1-a]isoindol-4(3H)-one (3a). 
The mixture of 2-aminoisoindole 
hydrobromide (0.43 g, 2 mmol), methyl 4-chloro-3-
oxobutanoate (0.38 g, 2.5 mmol) and triethylamine 
(0.25 g, 2.5 mmol) in dry dioxane (10 ml) were heated 
under reflux for 40 min. Precipitate formed after 
cooling was filtered off and purified by column 
chromatography on silica gel with ethyl acetate–
toluene (8:2) as eluent. 
Pale yellow powder (Yield 0.23 g, 46 %). M.p. 
174−175 °C. 1H NMR: δ = 2.62 (d, 1H, J=16 Hz), 2.80 
(d, 1H, J=16 Hz), 3.63 (d, 1H, J=12 Hz), 3.68 (d, 1H, 
J=12 Hz), 4.79 (s, 2H), 6.15 (s, 1H, OH), 7.47 (t, 1H, 
J=8 Hz) 7.49−7.63 (m, 2H), 7.82 (d, 1H, J=8 Hz) ppm. 
13C NMR: δ = 39.0, 48.6, 52.0, 86.2, 124.0, 124.5, 
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129.0, 133.1, 135.5, 141.2, 155.9, 166.0 ppm. [M+H]+ 
251. 
General procedure for preparation of amino 
alcohols 4. 
The mixture of compound 3a (0.5 g, 2 mmol) 
and aliphatic amine (3 mmol) in dry toluene (10 ml) 
were heated under reflux for 1 h. The solvent was 
evaporated and the residue was separated by column 
chromatography on silica gel with hexane-ethyl 
acetate (9:1) as eluent. 
2-Hydroxy-2-(morpholin-4-ylmethyl)-2,6-
dihydropyrimido[2,1-a]isoindol-4(3H)-one (4a). 
White powder (Yield 93 %). M.p. 192−193 
°C. 1H NMR: δ = 2.50−2.55 (m, 2H), 2.57−2.61 (m, 
4H), 3.47 (s, 2H), 3.65−3.71 (m, 4H), 5.05 (s, 1H), 
6.37 (s, 1H, OH), 7.59 (t, 1H, J=7.4 Hz), 7.67 (t, 1H, 
J=8 Hz), 7.76−7.78 (d, 1H, J=8 Hz), 7.99−8.01 (d, 1H, 
J=8 Hz) ppm. 13C NMR δ = 41.0, 49.2, 53.5, 62.8, 
65.8, 85.1, 125.2, 125.5, 127.1, 134.4, 136.0, 142.1, 
155.5, 166.7 ppm. [M+H]+ 302.  
2-Hydroxy-2-[(4-methylpiperazin-1-
yl)methyl]-2,6-dihydropyrimido[2,1-a]isoindol-
4(3H)-one (4b) 
Pale yellow powder (Yield 74 %). M.p. 
187−188 °C. 1H NMR: δ = 2.44 (s, 3H), 2.51−2.55 (m, 
2H), 3.35−3.40 (m, 4H), 3.51 (s, 2H), 3.95−4.11 (m, 
4H), 5.15 (s, 2H), 6.42 (s, 1H, OH), 7.61 (t, 1H, J=7.4 
Hz), 7.69 (t, 1H, J=8 Hz), 7.72−7.76 (d, 1H, J=8 Hz), 
7.96−7.98 (d, 1H, J=8 Hz) ppm. 13C NMR: δ = 40.2, 
46.0, 48.5, 53.1, 54.5, 64.1, 86.5, 123.8, 125.7, 128.3, 
133.9, 136.3, 144.0, 157.1, 165.8 ppm. [M+H]+ 315.  
4-[(2-Hydroxy-4-oxo-2,3,4,6-
tetrahydropyrimido[2,1-a]isoindol-2-
yl)methyl]piperazine-1-carbaldehyde (4c) 
Pale yellow powder (Yield 76 %). M.p. 
190−192 °C. 1H NMR: δ = 2.50−2.53 (m, 2H), 
3.32−2.38 (m, 4H), 3.48 (s, 2H), 3.97−3.99 (m, 2H), 
4.02−4.04 (m, 2H), 5.18 (s, 2H), 6.40 (s, 1H, OH), 7.62 
(t, 1H, J=7.4 Hz), 7.65 (t, 1H, J=8 Hz), 7.73−7.75 (d, 
1H, J=8 Hz), 7.91−7.93 (d, 1H, J=8 Hz), 8.40 (s, 1H) 
ppm. 13C NMR δ (DMSO-d6) 38.1; 42.1; 49.1; 51.8; 
62.2; 87.7; 125.2; 125.7; 129.6; 134.1; 135.9; 141.8; 
156.9; 160.1; 166.8 ppm. [M+H]+ 329.  
2-Hydroxy-2-[(propylamino)methyl]-2,6-
dihydropyrimido[2,1-a]isoindol-4(3H)-one (4d) 
Pale yellow powder (Yield 92 %). M.p. 
162−163 °C. 1H NMR: δ = 1.04 (t, 3H), 1.70−1.79 (m, 
2H), 3.57−3.61 (m, 2H), 3.52 (s, 2H), 5.14 (s, 2H), 
6.34 (s, 1H, OH), 7.55 (t, 1H, J=7.4 Hz), 7.62 (t, 1H, 
J=8 Hz), 7.70−7.72 (d, 1H, J=8 Hz), 7.88−7.90 (d, 1H, 
J=8 Hz) ppm. 13C NMR: δ = 10.8, 21.5, 39.7, 48.2, 
50.1, 59.0, 87.0, 125.3, 125.9, 130.3, 134.3, 137.0, 
142.4, 157.1, 167.1 ppm. [M+H]+ 274. 
2-Hydroxy-2-{[(3-
methoxypropyl)amino]methyl}-2,6-
dihydropyrimido[2,1-a]isoindol-4(3H)-one (4e) 
White powder (Yield 73 %). M.p. 167−168 
°C. 1H NMR: δ = 2.54−2.56 (m, 2H), 3.21 (s, 3H, 
OCH3), 3.50−3.52 (m, 2H), 3.96−3.98 (m, 2H), 3.48 
(s, 2H), 5.04 (s, 2H), 6.29 (s, 1H OH), 7.53 (t, 1H, 
J=7.4 Hz), 7.65 (t, 1H, J=8 Hz), 7.69−7.71 (d, 1H, J=8 
Hz), 7.92−7.94 (d, 1H, J=8 Hz) ppm. 13C NMR: δ = 
31.6, 39.5, 47.4, 49.6, 56.2, 57.2, 67.1, 87.7, 126.1, 
FRENCH-UKRAINIAN JOURNAL OF CHEMISTRY (2018, VOLUME 06, ISSUE 02)  
36 
 
126.8, 130.2, 134.2, 136.1, 143.1, 156.7, 167.2 ppm. 
[M+H]+ 304. 
2-Hydroxy-2-{[(2-
phenylethyl)amino]methyl}-2,6-dihydropyrimido[2,1-
a]isoindol-4(3H)-one (4f) 
Pale yellow powder (Yield 92 %). M.p. 191 
°C. 1H NMR: δ = 2.79−2.84 (m, 4H), 3.45 (s, 2H), 5.03 
(s, 2H), 6.30 (s, 1H, OH), 7.14−7.25 (m, 5H), 7.59 (t, 
1H, J=7.4 Hz), 7.67 (t, 1H, J=8 Hz), 7.74−7.76 (d, 1H, 
J=8 Hz), 7.95−7.97 (d, 1H, J=8 Hz) ppm. 13C NMR: δ 
= 34.5, 39.8, 48.5, 48.9, 57.2, 87.0, 124.6, 124.9, 125.9, 
126.8, 127.5, 131.1, 134.2, 136.7, 138.1, 143.2, 156.4, 
167.7 ppm. [M+H]+ 336. 
 
Conclusions 
Reaction of 1-aminoisoindole with methyl-4-
chloro-3-oxobutanoate occurs in a regioselective 
manner to provide 2-(chloromethyl)-2-hydroxy-2,6-
dihydropyrimido[2,1-a]-isoindol-4-(3H)-one 3a. A 
simple approach to novel biologically promising 
amino alcohols 4 was elaborated, which includes 
reaction of compound 3a with aliphatic amines. 
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